For citations:
Smirnov V.A., Khvostova M.A., Morozova Ya.V., Radaev S.M., Zuev S.E., Karanadze V.A., Barbakadze Z.A., Ryabov S.I., Zvyagintseva M.А., Bazanovich S.A., Kordonskiy A.Yu., Tsarev A.V., Talypov A.E., Grin A.A. Cell therapy for patients with severe spinal cord injury (phase I/IIа): Assessment of safety and primary efficacy of therapy. Russian journal of neurosurgery. 2025;27(2):43-69. https://doi.org/10.63769/1683-3295-2025-27-2-43-69
Views PDF (Eng): 100
JATS XML
Email this article 